Where to Inject CJC-1295 and Ipamorelin: Sites & Rotation

Every site below reaches the same target: the fat layer between skin and muscle. CJC-1295 and ipamorelin are dosed subcutaneously, and the clinical work behind CJC-1295 used exactly that route (Teichman et al., J Clin Endocrinol Metab, 2006, PMID 16352683).

Standard equipment is a 29 to 31 gauge insulin syringe with a 5/16 inch (8 mm) needle. Pinch a fold of skin, insert at 45 degrees, and push the plunger slowly. If you carry enough fat at the site, 90 degrees without a deep pinch also lands subcutaneous. Aspiration is unnecessary for subcutaneous injections.

Subcutaneous injection is the studied route for these peptides. CJC-1295 given subcutaneously raised GH 2 to 10 fold and IGF-1 1.5 to 3 fold in healthy adults, with effects lasting days (Teichman et al., J Clin Endocrinol Metab, 2006, PMID 16352683). That is the evidence base. Site-to-site absorption differences between belly and thigh are documented for insulin, and no equivalent head-to-head data exists for CJC-1295 or ipamorelin.

So pick sites by comfort and rotation, and ignore absorption folklore. Intramuscular injection has no demonstrated benefit for these peptides. It reaches deeper, hurts more, bleeds more, and leaves the studied route behind.

One syringe covers both compounds. Drawing CJC-1295 and ipamorelin together is standard practice; the reconstitution walkthrough for CJC-1295 and ipamorelin shows the two-vial draw, and the general reconstitution guide covers mixing technique.

Repeated injections into the same spot build lipohypertrophy: a rubbery fat lump under the skin that absorbs drugs erratically. The numbers come from people who inject daily, just like a GH peptide protocol. In 430 insulin-injecting patients, 64.4% had lipohypertrophy. Among those with lumps, 98% rotated incorrectly or not at all. Among correct rotators, only 5% had them (Blanco et al., Diabetes Metab, 2013, PMID 23886784).

That is the whole case for rotation, measured in the same subcutaneous tissue you are using. The fix costs nothing: a six-station loop.

Keep every stick at least 1 inch from the last one at that station. If you find a firm, rubbery patch, retire that zone for several weeks and let it recover. Injecting into a lump wastes the dose you paid for: absorption from hypertrophied tissue is unpredictable.

Inject 30 to 60 minutes before bed, on an empty stomach: roughly 2 hours after your last meal, and wait at least 20 to 30 minutes before eating anything after. Bedtime dosing stacks the peptides on top of the natural GH pulse that arrives with deep sleep.

The empty stomach rule has a mechanism behind it. Glucose ingestion triggers somatostatin release from the hypothalamus, and somatostatin is the brake on GH secretion (Shibasaki et al., Life Sci, 1989, PMID 2563893). Inject right after dinner and you are asking the pituitary to fire while the brake is pressed.

Ipamorelin suits bedtime use because of its selectivity. It releases GH without pushing ACTH or cortisol beyond GHRH-like levels (Raun et al., Eur J Endocrinol, 1998, PMID 9849822), so it does not wire you awake the way older secretagogues could. Timing decides when the pulse fires; dose size decides how big it is, and that lives in the CJC-1295 dosage guide.

A small red welt that itches for 10 to 60 minutes is the most common reaction, especially with ipamorelin. Users describe it as a histamine-like flare. It fades on its own and does not predict anything systemic. Mild bruising happens when the needle nicks a capillary; it is cosmetic.

Spreading redness, warmth, swelling that grows after day one, pus, or fever is a different category. That pattern suggests infection and deserves medical attention, not another injection.

To shrink the welts: hold the refrigerated syringe in your hand for 1 to 2 minutes so the solution warms, let the alcohol dry completely before inserting, inject over 5 to 10 seconds, wait 5 seconds before withdrawing, and skip rubbing the site. A fresh needle every time is non-negotiable; reused needles dull, drag, and contaminate. Storage and shelf-life rules for the mixed vial are in the reconstituted peptide shelf-life guide, and systemic effects are covered in the CJC-1295 and ipamorelin side effects guide.

Hitting muscle on a lean frame. No pinch, a 90 degree angle, and low body fat sends the needle through the fat layer into muscle: sharper pain, more bruising, and an unstudied absorption profile. Fix: 5/16 inch needle, a real pinch, 45 degrees.

Same-spot loyalty. The Blanco data splits 98% versus 5% on rotation alone (Blanco et al., Diabetes Metab, 2013, PMID 23886784). One favorite spot becomes one lump, and every future dose placed there underperforms. Fix: the six-station loop above.

Injecting after dinner. The glucose-driven somatostatin brake blunts the GH response. You feel nothing fail; the protocol just quietly underdelivers. Fix: 2 hours after the last meal, every time.

Injecting through the navel zone or waistband line. Denser tissue, more vessels, constant fabric friction. Fix: 2 inches of clearance from the navel and a site your waistband never touches. The same landmarking logic applies to other GH peptides, covered in the sermorelin injection site guide.